ALPS Advisors’s Anavex Life Sciences AVXL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$232K Buy
75,443
+2,082
+3% +$9.02K ﹤0.01% 987
2025
Q4
$261K Buy
73,361
+34,755
+90% +$213K ﹤0.01% 952
2025
Q3
$344K Sell
38,606
-7,474
-16% -$75.8K ﹤0.01% 942
2025
Q2
$425K Sell
46,080
-14,140
-23% -$121K ﹤0.01% 726
2025
Q1
$517K Sell
60,220
-8,346
-12% -$78.8K ﹤0.01% 587
2024
Q4
$736K Buy
68,566
+4,587
+7% +$35.3K ﹤0.01% 545
2024
Q3
$363K Sell
63,979
-2,070
-3% -$11.9K ﹤0.01% 791
2024
Q2
$279K Buy
66,049
+8,136
+14% +$32.9K ﹤0.01% 871
2024
Q1
$295K Buy
57,913
+1,782
+3% +$10K ﹤0.01% 905
2023
Q4
$523K Sell
56,131
-4,320
-7% -$29.7K ﹤0.01% 600
2023
Q3
$396K Buy
60,451
+1,031
+2% +$8.21K ﹤0.01% 626
2023
Q2
$483K Buy
59,420
+8,007
+16% +$68.6K ﹤0.01% 618
2023
Q1
$441K Sell
51,413
-1,511
-3% -$15.1K ﹤0.01% 603
2022
Q4
$490K Buy
52,924
+10,424
+25% +$111K ﹤0.01% 595
2022
Q3
$439K Sell
42,500
-3,426
-7% -$36.2K ﹤0.01% 631
2022
Q2
$460K Sell
45,926
-32,360
-41% -$307K ﹤0.01% 624
2022
Q1
$964K Sell
78,286
-9,686
-11% -$119K 0.01% 316
2021
Q4
$1.52M Buy
+87,972
New +$1.67M 0.02% 317

Other funds holding AVXL